Background: This study aimed at creating a new predictive model of significant fibrosis in chronic hepatitis B using direct and indirect parameters and comparing this model with other noninvasive models for its validation in clinical settings
AIM: To correlate liver stiffness measurements with demographic and laboratory parameters, and asses...
Background: Liver stiffness measurement (LSM) using transient elastography (FibroScanH) can assess l...
Aim: To correlate liver stiffness with demographical factors and routine liver biochemistry and to a...
Background: This study aimed at creating a new predictive model of significant fibrosis in chronic h...
OBJECTIVE: We developed a predictive model for significant fibrosis in chronic hepatitis B (CHB) bas...
We developed a predictive model for significant fibrosis in chronic hepatitis B (CHB) based on routi...
Background and Aims Noninvasive models have been developed for fibrosis assessment in patients with ...
<div><p>Background and Aims</p><p>Noninvasive models have been developed for fibrosis assessment in ...
Background. Preventing liver fibrosis from progressing to cirrhosis and even liver cancer is a key s...
Background and goals: Liver fibrosis influences treatment and surveillance strategies in chronic hep...
Objective: We developed a predictive model for significant fibrosis in chronic hepatitis B (CHB) bas...
BACKGROUND/AIMS: The majority of non-invasive markers of liver fibrosis have been developed in patie...
WOS: 000429311600004Background: Manynoninvasive methods, including aspartateaminotransaminase (AST)/...
Background: Some controversy remains regarding conventional serum indices for the evaluation of live...
Liver stiffness measurement (LSM) using transient elastography (FibroScan®) can assess liver fibrosi...
AIM: To correlate liver stiffness measurements with demographic and laboratory parameters, and asses...
Background: Liver stiffness measurement (LSM) using transient elastography (FibroScanH) can assess l...
Aim: To correlate liver stiffness with demographical factors and routine liver biochemistry and to a...
Background: This study aimed at creating a new predictive model of significant fibrosis in chronic h...
OBJECTIVE: We developed a predictive model for significant fibrosis in chronic hepatitis B (CHB) bas...
We developed a predictive model for significant fibrosis in chronic hepatitis B (CHB) based on routi...
Background and Aims Noninvasive models have been developed for fibrosis assessment in patients with ...
<div><p>Background and Aims</p><p>Noninvasive models have been developed for fibrosis assessment in ...
Background. Preventing liver fibrosis from progressing to cirrhosis and even liver cancer is a key s...
Background and goals: Liver fibrosis influences treatment and surveillance strategies in chronic hep...
Objective: We developed a predictive model for significant fibrosis in chronic hepatitis B (CHB) bas...
BACKGROUND/AIMS: The majority of non-invasive markers of liver fibrosis have been developed in patie...
WOS: 000429311600004Background: Manynoninvasive methods, including aspartateaminotransaminase (AST)/...
Background: Some controversy remains regarding conventional serum indices for the evaluation of live...
Liver stiffness measurement (LSM) using transient elastography (FibroScan®) can assess liver fibrosi...
AIM: To correlate liver stiffness measurements with demographic and laboratory parameters, and asses...
Background: Liver stiffness measurement (LSM) using transient elastography (FibroScanH) can assess l...
Aim: To correlate liver stiffness with demographical factors and routine liver biochemistry and to a...